These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4147726

  • 1. The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs.
    Thornburg JE, Moore KE.
    Neuropharmacology; 1973 Sep; 12(9):853-66. PubMed ID: 4147726
    [No Abstract] [Full Text] [Related]

  • 2. The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by beta-phenethylamine.
    Jackson DM.
    J Pharm Pharmacol; 1974 Aug; 26(8):651-4. PubMed ID: 4155737
    [No Abstract] [Full Text] [Related]

  • 3. Supersensitivity to the central stimulant actions of adrenergic drugs following discontinuation of a chronic diet of alpha-methyltyrosine.
    Dominic JA, Moore KE.
    Psychopharmacologia; 1969 Aug; 15(2):96-101. PubMed ID: 4390822
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
    Breese GR, Cooper BR, Hollister AS.
    Psychopharmacologia; 1975 Oct 14; 44(1):5-10. PubMed ID: 128026
    [Abstract] [Full Text] [Related]

  • 10. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L, Anisman H.
    Psychopharmacology (Berl); 1979 Jun 28; 64(1):45-54. PubMed ID: 113831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J.
    Eur J Pharmacol; 1971 Jun 28; 14(1):47-59. PubMed ID: 4396660
    [No Abstract] [Full Text] [Related]

  • 13. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC, Giardina WJ, Myles SB, Vazquez AJ.
    Arzneimittelforschung; 1974 Mar 28; 24(3):333-7. PubMed ID: 4407412
    [No Abstract] [Full Text] [Related]

  • 14. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH, Davis WM.
    J Pharmacol Exp Ther; 1977 Jul 28; 202(1):182-91. PubMed ID: 17725
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF, Loh HH.
    J Pharmacol Exp Ther; 1974 Jun 28; 189(3):717-24. PubMed ID: 4858403
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats.
    Lassen JB.
    Psychopharmacologia; 1974 Jun 28; 37(4):331-40. PubMed ID: 4136728
    [No Abstract] [Full Text] [Related]

  • 19. Dopaminergic nature of amphetamine-induced pecking in pigeons.
    Cheng HC, Bhatnagar RK, Long JP.
    Eur J Pharmacol; 1975 Jun 28; 33(2):319-24. PubMed ID: 1237409
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.